Valeant, Pershing Square Plan to Boost Allergan Bid by $15 a Share
Valeant Pharmaceuticals International Inc. VRX.T -2.19% and activist investor William Ackman are planning to boost their offer for Allergan Inc. AGN +1.68% by $15 a share, according to people familiar with the matter.
The price bump would bring the offer from Valeant and Mr. Ackman’s Pershing Square Capital Management LP to about $191 a share based on Valeant’s closing price Tuesday. That is 2.5% above the closing price of Allergan’s shares, which rose Tuesday to $186.20. The new bid would be about 8% higher than the current offer.
The bidders are still ironing out questions of timing and the mix of cash and stock for the additional $15-per-share rise, the people said.